"ｍRNA" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonmRNA vaccine immunity is enhanced by hepatocyte detargeting and not dependent on dendritic cell e...
Rethinking mRNA vaccines: Liver targeting can suppress immunity, while muscle boosts it - Medical...
Rethinking mRNA vaccines: Liver targeting can suppress immunity, while muscle boosts it Medical Xpress
GSK walks away from $100M bet on Mersana's STING ADC, pauses mRNA bird flu shot program - Fierce ...
GSK walks away from $100M bet on Mersana's STING ADC, pauses mRNA bird flu shot program Fierce Biotech
New Immune Pathway Could Supercharge mRNA Cancer Vaccines - SciTechDaily
New Immune Pathway Could Supercharge mRNA Cancer Vaccines SciTechDaily
Moderna (MRNA) Q1 2026 Earnings Transcript - The Motley Fool
Moderna (MRNA) Q1 2026 Earnings Transcript The Motley Fool
Polymarket Earnings: Will CVX, XOM, MRNA Beat Earnings Tomorrow? - TipRanks
Polymarket Earnings: Will CVX, XOM, MRNA Beat Earnings Tomorrow? TipRanks
Translation-dependent degradation of cas12 mRNA triggered by an anti-CRISPR - Nature
Translation-dependent degradation of cas12 mRNA triggered by an anti-CRISPR Nature
Moderna Q1 Earnings: Revenue Beat Overshadowed By Litigation Charge, Pipeline Drives Outlook - Se...
Moderna Q1 Earnings: Revenue Beat Overshadowed By Litigation Charge, Pipeline Drives Outlook Seeking Alpha
Tuning the immune response to mRNA vaccines - Nature
Investigational Pancreatic Cancer Vaccine Shows Lasting Results in Early Trial, Supporting Contin...
Investigational Pancreatic Cancer Vaccine Shows Lasting Results in Early Trial, Supporting Continued Testing Memorial Sloan Kettering Cancer Center
Legal settlement drives Q1 2026 loss at Moderna (NASDAQ: MRNA) - Stock Titan
Legal settlement drives Q1 2026 loss at Moderna (NASDAQ: MRNA) Stock Titan
Study Overturns Assumption about how mRNA Vaccines Work - Labcompare
Study Overturns Assumption about how mRNA Vaccines Work Labcompare
Moderna (MRNA) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance
Moderna (MRNA) Reports Q1 Loss, Beats Revenue Estimates Yahoo Finance
mRNA vaccines follow unconventional immune path to destroy tumors - WashU Medicine
mRNA vaccines follow unconventional immune path to destroy tumors WashU Medicine
Pancreatic cancer mRNA vaccine shows lasting results in an early trial - NBC News
Pancreatic cancer mRNA vaccine shows lasting results in an early trial NBC News
Moderna (MRNA) Reports Strong Q1 2026 Performance with $400 Million Revenue - GuruFocus
Moderna (MRNA) Reports Strong Q1 2026 Performance with $400 Million Revenue GuruFocus
Moderna’s Strong Vaccine Sales Outside US Far Surpass Estimates - Bloomberg.com
Moderna’s Strong Vaccine Sales Outside US Far Surpass Estimates Bloomberg.com
MRNA Stock Rises Pre-Market: Moderna Bets On US Comeback With Flu Vaccine Pipeline - Stocktwits
MRNA Stock Rises Pre-Market: Moderna Bets On US Comeback With Flu Vaccine Pipeline Stocktwits
After a year of turmoil, cancer researchers see promising signs for mRNA vaccines - CNN
After a year of turmoil, cancer researchers see promising signs for mRNA vaccines CNN
Moderna (NASDAQ:MRNA) Beats Expectations in Strong Q1 CY2026, Stock Soars - FinancialContent
Moderna (NASDAQ:MRNA) Beats Expectations in Strong Q1 CY2026, Stock Soars FinancialContent
Rare myocarditis after mRNA vaccination: Mitochondrial stress identified as a key factor - Medica...
Rare myocarditis after mRNA vaccination: Mitochondrial stress identified as a key factor Medical Xpress
A multiobjective AI model for LNP engineering enhances tissue-selective mRNA delivery - Nature
A multiobjective AI model for LNP engineering enhances tissue-selective mRNA delivery Nature
Engineered cells as programmable mRNA delivery vehicles - Nature
Engineered cells as programmable mRNA delivery vehicles Nature
mRNA vaccines engage unconventional pathways in CD8+ T cell priming - Nature
mRNA vaccines engage unconventional pathways in CD8+ T cell priming Nature
Moderna, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:MRNA) 2026-05-01 - Seeking A...
Moderna, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:MRNA) 2026-05-01 Seeking Alpha
Moderna stock jumps after Q1 2026 beat (MRNA:NASDAQ) - Seeking Alpha
Moderna stock jumps after Q1 2026 beat (MRNA:NASDAQ) Seeking Alpha
EU clears Moderna's flu-COVID shot as Q1 loss hits $1.3B - Stock Titan
EU clears Moderna's flu-COVID shot as Q1 loss hits $1.3B Stock Titan
[144] Moderna, Inc. SEC Filing - Stock Titan
[144] Moderna, Inc. SEC Filing Stock Titan
Why Is Moderna Stock Falling Friday? - Moderna (NASDAQ:MRNA) - Benzinga
Why Is Moderna Stock Falling Friday? - Moderna (NASDAQ:MRNA) Benzinga
Moderna (NASDAQ: MRNA) grows Q1 2026 revenue but books $1.3B loss - Stock Titan
Moderna (NASDAQ: MRNA) grows Q1 2026 revenue but books $1.3B loss Stock Titan
Moderna: Q1 Earnings Snapshot - KING5.com
Moderna: Q1 Earnings Snapshot KING5.com
mRNABERT: advancing mRNA sequence design with a universal language model and comprehensive datase...
mRNABERT: advancing mRNA sequence design with a universal language model and comprehensive dataset Nature
Moderna stocks: MRNA shares jump in US Stock market today after pharma giant surpasses Wall Stree...
Moderna stocks: MRNA shares jump in US Stock market today after pharma giant surpasses Wall Street estimat The Economic Times
Moderna (MRNA): 10 Best Performing S&P 500 Stocks So Far in 2026 - Yahoo Finance
Moderna (MRNA): 10 Best Performing S&P 500 Stocks So Far in 2026 Yahoo Finance
Moderna (MRNA) Reports Earnings Tomorrow: What To Expect - StockStory
Moderna (MRNA) Reports Earnings Tomorrow: What To Expect StockStory
Laguna Diagnostics mRNA Gene Biomarker Test Gets FDA Breakthrough Device Status - Contract Pharma
Laguna Diagnostics mRNA Gene Biomarker Test Gets FDA Breakthrough Device Status Contract Pharma
Expanding global access to mRNA vaccines - Nature
New mRNA Therapy Uses Red Blood Cells to Attack Tumours from Within - The Indian Practitioner
New mRNA Therapy Uses Red Blood Cells to Attack Tumours from Within The Indian Practitioner
Malaria parasite sneaks mRNA into immune cell nuclei, disrupting defenses - Phys.org
Malaria parasite sneaks mRNA into immune cell nuclei, disrupting defenses Phys.org
Moderna Q1 preview: revenue rebound in focus as losses persist (MRNA:NASDAQ) - Seeking Alpha
Moderna Q1 preview: revenue rebound in focus as losses persist (MRNA:NASDAQ) Seeking Alpha
Comparative study of analytical methods for assessing mRNA integrity and identification of functi...
ESMO 2025: mRNA-based COVID vaccines generate improved responses to immunotherapy - UT MD Anderson
ESMO 2025: mRNA-based COVID vaccines generate improved responses to immunotherapy UT MD Anderson
Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine - The New England Journal...
Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine The New England Journal of Medicine
Why you should keep getting mRNA vaccines - Scientific American
Why you should keep getting mRNA vaccines Scientific American
HHS Winds Down mRNA Vaccine Development Under BARDA - HHS.gov
New report sounds alarm on health fallout from mRNA vaccine funding cuts - Yale School of Public ...
New report sounds alarm on health fallout from mRNA vaccine funding cuts Yale School of Public Health
Media Coverage of Study Finding COVID-19 mRNA Vaccine Sparks Immune Response to Fight Cancer - UF...
Media Coverage of Study Finding COVID-19 mRNA Vaccine Sparks Immune Response to Fight Cancer UF Health
Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC - Nature
Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC Nature
How a rapid-response bird flu vaccine trial is shaping global preparedness - Gavi, the Vaccine Al...
How a rapid-response bird flu vaccine trial is shaping global preparedness Gavi, the Vaccine Alliance
Earnings Flash (MRNA) Moderna Posts Q1 Loss $3.40 a Share, vs. FactSet Est of $4.45 Loss - market...
Earnings Flash (MRNA) Moderna Posts Q1 Loss $3.40 a Share, vs. FactSet Est of $4.45 Loss marketscreener.com
Breaking barriers in prostate cancer: the mRNA vaccine breakthrough and what comes next - Nature
Breaking barriers in prostate cancer: the mRNA vaccine breakthrough and what comes next Nature
Earnings Flash (MRNA) Moderna, Inc. Reports Q1 Revenue $389.0M, vs. FactSet Est of $236.4M - mark...
Earnings Flash (MRNA) Moderna, Inc. Reports Q1 Revenue $389.0M, vs. FactSet Est of $236.4M marketscreener.com
Loop structure in poly(A) tail of mRNA vaccine enhances antigen translation efficiency and mRNA s...
Why mRNA is important for U.S. national security - Hopkins Bloomberg Center
Why mRNA is important for U.S. national security Hopkins Bloomberg Center
Moderna developed an mRNA Covid-flu combo vaccine and it’s b... - Kottke.org
Moderna developed an mRNA Covid-flu combo vaccine and it’s b... Kottke.org
Association of mRNA COVID-19 vaccination with overall survival in patients receiving immune check...
MRNA Vaccine Misinformation Threatens Cancer Treatment Breakthroughs - FlaglerLive
MRNA Vaccine Misinformation Threatens Cancer Treatment Breakthroughs FlaglerLive
Moderna loses key mRNA patent in European vaccine fight - Life Sciences Intellectual Property Review
Moderna loses key mRNA patent in European vaccine fight Life Sciences Intellectual Property Review
Establishing long-lasting vaccine immunity: insights from mRNA and adjuvanted protein platforms -...
Establishing long-lasting vaccine immunity: insights from mRNA and adjuvanted protein platforms Nature
Is Moderna (MRNA) Pricing Make Sense After 77% One-Year Surge And DCF Signal? - Yahoo Finance
Is Moderna (MRNA) Pricing Make Sense After 77% One-Year Surge And DCF Signal? Yahoo Finance
Moderna (MRNA) Misses Q1 EPS by $1.38, Beats on Revenue - StreetInsider
Moderna (MRNA) Misses Q1 EPS by $1.38, Beats on Revenue StreetInsider
People with some cancers live longer after a COVID vaccine - Nature
People with some cancers live longer after a COVID vaccine Nature
U.S. rejection of new mRNA flu vaccine 'sends chills,' epidemiologist says - PBS
U.S. rejection of new mRNA flu vaccine 'sends chills,' epidemiologist says PBS
Adverse events following SARS-CoV-2 mRNA vaccination in norwegian adolescents - Nature
Adverse events following SARS-CoV-2 mRNA vaccination in norwegian adolescents Nature
mRNA-1010 influenza vaccine elicits distinct and enhanced humoral immunity compared to adjuvanted...
Cancer vaccines could transform treatment and prevention – but misinformation about mRNA vaccines...
Cancer vaccines could transform treatment and prevention – but misinformation about mRNA vaccines threatens their potential The Conversation
‘Type’ Casting: Flagship-Founded Serif Modifying DNA into New Therapy Class - Genetic Engineering...
‘Type’ Casting: Flagship-Founded Serif Modifying DNA into New Therapy Class Genetic Engineering and Biotechnology News
SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade - Nature
SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade Nature
Understanding the Impact of Federal Cuts to mRNA Vaccine Research - American Lung Association
Understanding the Impact of Federal Cuts to mRNA Vaccine Research American Lung Association
Slashing of funding for mRNA vaccine development raises concern - Harvard T.H. Chan School of Pub...
Slashing of funding for mRNA vaccine development raises concern Harvard T.H. Chan School of Public Health
Moderna’s H5N1 Vaccine Trial Draws Support As Valuation Stays Stretched - simplywall.st
Moderna’s H5N1 Vaccine Trial Draws Support As Valuation Stays Stretched simplywall.st
US vaccine panel retreats from mRNA Covid review ahead of midterms | Trump administration - The G...
US vaccine panel retreats from mRNA Covid review ahead of midterms | Trump administration The Guardian
F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine - The New York Times
F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine The New York Times
Study finds COVID-19 mRNA vaccine sparks immune response to fight cancer - UF Health
Study finds COVID-19 mRNA vaccine sparks immune response to fight cancer UF Health
Vanguard Capital Management (MRNA) reports 25.9M-share stake (6.53%) - Stock Titan
Vanguard Capital Management (MRNA) reports 25.9M-share stake (6.53%) Stock Titan
Cancelling mRNA studies is the highest irresponsibility - Nature
Cancelling mRNA studies is the highest irresponsibility Nature
FDA refuses to review Moderna’s application for mRNA flu vaccine, company says - CNN
FDA refuses to review Moderna’s application for mRNA flu vaccine, company says CNN
News Tips: Basic Scientists at Johns Hopkins Medicine Study mRNA Technology to Develop Promising ...
News Tips: Basic Scientists at Johns Hopkins Medicine Study mRNA Technology to Develop Promising Treatments Johns Hopkins Medicine
How Cuts to mRNA Vaccine Development Will Set the U.S. Back - Johns Hopkins Bloomberg School of P...
How Cuts to mRNA Vaccine Development Will Set the U.S. Back Johns Hopkins Bloomberg School of Public Health
Personalized cancer vaccines are almost here—but federal funding cuts could derail them - Scienti...
Personalized cancer vaccines are almost here—but federal funding cuts could derail them Scientific American
Experimental mRNA flu vaccine is more effective than conventional flu shot, but causes more side ...
Halting mRNA Research Could Deepen the Public’s Distrust and Uncertainty about Vaccine Safety – w...
The mRNA component of LNP-mRNA vaccines triggers IFNAR-dependent immune activation which attenuat...
Europe—not US—first to authorize Moderna’s combo mRNA flu-COVID vaccine - Ars Technica
Europe—not US—first to authorize Moderna’s combo mRNA flu-COVID vaccine Ars Technica
mRNA COVID vaccines tied to drop in death rate for 4 years - CIDRAP
mRNA COVID vaccines tied to drop in death rate for 4 years CIDRAP
Evaluating the safety of XBB.1.5-containing COVID-19 mRNA vaccines using a self-controlled case s...
Systematic analysis of COVID-19 mRNA vaccines using four orthogonal approaches demonstrates no ex...
2026-04 - Targeting lung immunity in the race for better TB vaccines - Wits University
2026-04 - Targeting lung immunity in the race for better TB vaccines Wits University
Promising signs for mRNA cancer vaccines - Juta MedicalBrief
Promising signs for mRNA cancer vaccines Juta MedicalBrief
Scientists Explain How mRNA COVID Vaccines May Rarely Cause Myocarditis - Scientific American
Scientists Explain How mRNA COVID Vaccines May Rarely Cause Myocarditis Scientific American
mRNA Vaccines Are a Game Changer—Here’s Why - Scientific American
mRNA Vaccines Are a Game Changer—Here’s Why Scientific American
Future mRNA vaccines may prevent food and seasonal allergies - Penn Medicine
Future mRNA vaccines may prevent food and seasonal allergies Penn Medicine
mRNA vaccines for HIV trigger strong immune response in people - Nature
mRNA vaccines for HIV trigger strong immune response in people Nature
Moderna Stock 5-Day Losing Spree: Stock Falls 18% - Trefis
FDA refuses to review Moderna's mRNA flu shot - NBC News
Federal mRNA funding cut is 'most dangerous public health decision' ever, expert says - PBS
Federal mRNA funding cut is 'most dangerous public health decision' ever, expert says PBS
New NIST Research Grade Test Material to support mRNA therapeutics - National Institute of Standa...
New NIST Research Grade Test Material to support mRNA therapeutics National Institute of Standards and Technology (.gov)
COVID-19 mRNA vaccines could unlock the next revolution in cancer treatment – new research - The ...
COVID-19 mRNA vaccines could unlock the next revolution in cancer treatment – new research The Conversation
RFK Jr cancels $500m in mRNA vaccine development in the US - BBC
RFK Jr cancels $500m in mRNA vaccine development in the US BBC
A look at how mRNA vaccines work as RFK Jr. cancels government-funded research - PBS
A look at how mRNA vaccines work as RFK Jr. cancels government-funded research PBS